CXCR4 and neoplasm: As a critical mediator of tumor–stroma interactions, CXCL12/CXCR4 axis plays an important role in the bidirectional tumor-stromal interaction, and therefore may be a promising prognostic marker and therapeutic target in PDAC [28], [29].